- Home
- ALGS vs JFU Comparison
ALGS vs JFU Comparison
Compare ALGS & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALGS | JFU |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | China |
| Employees | 82 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.0M | 46.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALGS | JFU |
|---|---|---|
| Price | $4.90 | $2.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 121.7K | 6.3K |
| Earning Date | 05-05-2026 | 12-09-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $32.20 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | ★ N/A | $1.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.01 | $1.25 |
| 52 Week High | $13.69 | $9.48 |
Technical Indicators
Market Signals| Indicator | ALGS | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 34.64 | 38.46 |
| Support Level | N/A | $2.87 |
| Resistance Level | $6.82 | $3.25 |
| Average True Range (ATR) | 0.41 | 0.29 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 7.63 | 3.19 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About JFU 9F Inc.
9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.